A molecular analysis of cervical cancers treated on EMBRACE indicate the minority (13%) of patients with p16(-) disease and those with MRI-apparent tumor necrosis have more radioresistant disease, particularly when PD-L1 was co-expressed. | Chopra. Int J Radiat Oncol biol Phys 2024

